Cipta Sarana Medika Tbk. vs Venteny Fortuna International Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Venteny Fortuna International Tbk. trades at Rp63 (market cap 375.91B, 19.73M 24h volume). The key difference: Venteny Fortuna International Tbk. is far larger — about 2.4× Cipta Sarana Medika Tbk.'s market cap, and Venteny Fortuna International Tbk. is more actively traded (19.73M versus 8.21M). Which is the better fit depends on your goals.
| DKHH | VTNY | |
|---|---|---|
Market Cap | 158.12B | 375.91B |
Volume | 8.21M | 19.73M |
Lot | 82.15K | 197.27K |
Turnover | 515.2M | 1.23B |
Average Price | 62.72 | 62.32 |
Value | 515.2M | 1.23B |
Indicative Equilibrium Price | 63 | 63 |
Indicative Equilibrium Volume | 1.33K | 3.58K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Venteny Fortuna International Tbk (the Entity) was established based on Notarial Deed No. 7,dated January 29, 2021 of Anastasia Chandra, S.H., M.Kn., Notary in Tangerang. The Entity started its commercial operations in 2021. PT Venteny Fortuna International Tbk is the parent entity, whereas Junichiro Waide is the ultimate beneficial owner.
Read more on VTNY →